Policy / Pricing Erica Schwartz, ex-deputy surgeon general, picked to be next CDC director BioPharma DiveIf confirmed by the Senate, Schwartz could finally fill a void for an agency that s cycled through multiple leaders over the last year.Policy / PricingRead full story pharminent April 16, 2026 (Last updated: April 17, 2026) BioPharma Dive If confirmed by the Senate, Schwartz could finally fill a void for an agency that s cycled through multiple leaders over the last year. Policy / PricingRead full story Post navigation Previous: FDA moves toward easing restrictions on certain peptidesNext: Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions Related Stories Policy / Pricing Mid-cap biotechs join Trump’s latest round of drug pricing deals pharminent September 1, 2026 Policy / Pricing MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones pharminent August 27, 2026 Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026